Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.9	2.94	14.92	22.97	88.61	42.98
Short-Term Investments	19.58	26.81	43.63	58.29	1.26	4.34
Cash & Short-Term Investments	21.48	29.75	58.55	81.26	89.86	47.31
Cash Growth	-57.01%	-49.19%	-27.95%	-9.57%	89.94%	5197.30%
Accounts Receivable	0.14	0.13	0.3	3.45	20.84	12.14
Other Receivables	-	-	0.03	1.87	-	-
Receivables	0.14	0.13	0.33	5.4	20.91	12.14
Inventory	1.08	1.07	1.66	5.31	2	8
Prepaid Expenses	1.13	1.34	1.6	0.76	2.34	0.37
Total Current Assets	23.83	32.29	62.14	92.73	115.12	67.81
Property, Plant & Equipment	4.49	4.88	6	2.91	1.93	0.95
Long-Term Investments	0.73	0.73	0.77	0.67	1	1.93
Goodwill	-	-	-	-	14.71	-
Other Intangible Assets	26.1	26.1	26.4	26.77	27.2	-
Long-Term Deferred Tax Assets	-	-	-	-	-	0.55
Total Assets	55.15	64	95.32	123.09	160.03	71.24
Accounts Payable	2.71	3.29	1.48	0.95	0.61	0.6
Accrued Expenses	1.61	2.56	2.17	0.93	3.86	2.97
Current Portion of Leases	0.9	0.92	0.84	0.3	-	-
Current Income Taxes Payable	-	-	-	-	2.21	0.19
Current Unearned Revenue	0.04	0.04	0.36	-	0.15	0.31
Other Current Liabilities	0.11	0.5	0.89	1.69	5.77	-
Total Current Liabilities	5.38	7.32	5.75	3.87	12.6	4.06
Long-Term Leases	1.03	1.24	2.15	0.05	-	-
Long-Term Deferred Tax Liabilities	-	-	-	2.42	7.23	-
Other Long-Term Liabilities	0.82	1.14	1.41	2.22	5.73	0.48
Total Liabilities	7.23	9.69	9.31	8.57	25.56	4.54
Common Stock	0.04	0.04	0.04	0.03	0.03	0.03
Additional Paid-In Capital	103.7	102.47	96.81	88.47	80.27	49.16
Retained Earnings	-40.57	-33.04	4.6	39.93	54.17	17.51
Treasury Stock	-15.58	-15.58	-15.58	-14.21	-	-
Comprehensive Income & Other	0.33	0.42	0.15	0.29	-	-
Total Common Equity	47.92	54.31	86.01	114.52	134.48	66.7
Shareholders' Equity	47.92	54.31	86.01	114.52	134.48	66.7
Total Liabilities & Equity	55.15	64	95.32	123.09	160.03	71.24
Total Debt	1.93	2.15	2.99	0.35	-	-
Net Cash (Debt)	19.55	27.6	55.56	80.91	89.86	47.31
Net Cash Growth	-58.56%	-50.33%	-31.34%	-9.96%	89.94%	5197.30%
Net Cash Per Share	0.63	0.91	1.89	2.57	3.01	1.69
Filing Date Shares Outstanding	33.71	33.57	31.26	30.92	33.97	28.67
Total Common Shares Outstanding	33.57	33.05	31.26	30.87	33.82	28.56
Working Capital	18.45	24.98	56.39	88.86	102.52	63.75
Book Value Per Share	1.43	1.64	2.75	3.71	3.98	2.34
Tangible Book Value	21.82	28.21	59.61	87.75	92.57	66.7
Tangible Book Value Per Share	0.65	0.85	1.91	2.84	2.74	2.34
Machinery	-	5.09	4.72	3.69	2.55	1.25
Leasehold Improvements	-	0.95	0.55	0.22	0	0

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q